26.03.2019 - The National Congress: "The Formula for the Future. What is necessary for the innovative Pharmaceutical and Medical Industry in Russia?"
The Russian market is moving to a new stage of its development, implying a large-scale attraction of advanced innovative technologies of the global pharmaceutical and medical industry. For representatives of government and market participants it becomes particularly important to introduce innovative products in a full-cycle format: from applied development to implementation, and the creation of conditions for this. More than 200 professionals in the pharmaceutical and medical devices industry will gather on March 26 in Moscow at the National Congress “The Formula of the Future” to discuss mechanisms for financing innovations, bringing them to market, and increasing their accessibility to patients.
Leading associations of the pharmaceutical industry identified risks to drug provision due to a radical change in T&T concept
December 18, 2018, Moscow – The pharmaceutical industry professional associations called for maintaining the technical conditions for implementing the project for monitoring the movement of medicines within the framework of the requirements developed earlier in the pilot project. At the same time, the Association of Russian Pharmaceutical Manufacturers, the Association of International Pharmaceutical Manufacturers, the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union, the APF National Association of Pharmaceutical and Medical Products Manufacturers, the Soyuzpharma Association of Pharmaceutical Institutions reaffirmed the principled commitment of their associations to the implementation of a system of labeling and traceability of medicines.
Introducing company interests, on which share it is necessary about 80 % made and sold in the world of pharmaceutical production and the medical equipment, AIPM considers as the priority cooperation with the Russian bodies of public health services, and also with legislative and executive branches of the power, for the purpose of working out of the program of creation of favorable conditions for sale and-or production of the international pharmaceutical companies in territory of the Russian Federation